NCT03108703View on ClinicalTrials.gov

Assessment of QoL and Outcomes With SBRT for RCC

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Renal Cell Carcinoma
Interventions
RADIATION

SBRT

35-40 Gy delivered in 5 fractions

Trial Locations (2)

L8V 5C2

Juravinski Cancer Centre, Hamilton

M4N 3M5

Odette Cancer Centre, Sunnybrook Health Science Centre, Toronto

All Listed Sponsors
collaborator

Juravinski Cancer Center

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER

NCT03108703 - Assessment of QoL and Outcomes With SBRT for RCC | Biotech Hunter | Biotech Hunter